These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 36892041)

  • 21. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and outcomes of patients with severe left ventricular dysfunction undergoing cardiac MRI viability assessment prior to revascularization.
    Doukas D; Porcaro K; Marot J; Burke L; Joyce C; Weaver F; Nguyen J; Cao JJ; Mathew V; Heroux A; Syed MA
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):675-684. PubMed ID: 33034865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial Viability Assessment Before Surgical Revascularization in Ischemic Cardiomyopathy: JACC Review Topic of the Week.
    Panza JA; Chrzanowski L; Bonow RO
    J Am Coll Cardiol; 2021 Sep; 78(10):1068-1077. PubMed ID: 34474740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial.
    Perera D; Ryan M; Morgan HP; Greenwood JP; Petrie MC; Dodd M; Weerackody R; O'Kane PD; Masci PG; Nazir MS; Papachristidis A; Chahal N; Khattar R; Ezad SM; Kapetanakis S; Dixon LJ; De Silva K; McDiarmid AK; Marber MS; McDonagh T; McCann GP; Clayton TC; Senior R; Chiribiri A;
    JAMA Cardiol; 2023 Dec; 8(12):1154-1161. PubMed ID: 37878295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: results of the Surgical Treatment for Ischemic Heart Failure trial.
    Holly TA; Bonow RO; Arnold JM; Oh JK; Varadarajan P; Pohost GM; Haddad H; Jones RH; Velazquez EJ; Birkenfeld B; Asch FM; Malinowski M; Barretto R; Kalil RA; Berman DS; Sun JL; Lee KL; Panza JA
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2677-84.e1. PubMed ID: 25152476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of preoperative positron emission tomography in patients with severely impaired LV-function undergoing surgical revascularization.
    Boehm J; Haas F; Bauernschmitt R; Wagenpfeil S; Voss B; Schwaiger M; Lange R
    Int J Cardiovasc Imaging; 2010 Apr; 26(4):423-32. PubMed ID: 20091350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
    Panza JA; Ellis AM; Al-Khalidi HR; Holly TA; Berman DS; Oh JK; Pohost GM; Sopko G; Chrzanowski L; Mark DB; Kukulski T; Favaloro LE; Maurer G; Farsky PS; Tan RS; Asch FM; Velazquez EJ; Rouleau JL; Lee KL; Bonow RO
    N Engl J Med; 2019 Aug; 381(8):739-748. PubMed ID: 31433921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is ischemia the most powerful indicator of myocardial viability?
    Shirani J
    Curr Cardiol Rep; 2013 May; 15(5):354. PubMed ID: 23512623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease.
    Mc Ardle B; Shukla T; Nichol G; deKemp RA; Bernick J; Guo A; Lim SP; Davies RA; Haddad H; Duchesne L; Hendry P; Masters R; Ross H; Freeman M; Gulenchyn K; Racine N; Humen D; Benard F; Ruddy TD; Chow BJ; Mielniczuk L; DaSilva JN; Garrard L; Wells GA; Beanlands RS;
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27609816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
    Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R
    Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revascularization in Ischemic Heart Failure with Reduced Left Ventricular Ejection Fraction.
    Gasior P; Wojakowski W; Kedhi E
    Curr Cardiol Rep; 2023 May; 25(5):401-409. PubMed ID: 37010802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial.
    Wrobel K; Stevens SR; Jones RH; Selzman CH; Lamy A; Beaver TM; Djokovic LT; Wang N; Velazquez EJ; Sopko G; Kron IL; DiMaio JM; Michler RE; Lee KL; Yii M; Leng CY; Zembala M; Rouleau JL; Daly RC; Al-Khalidi HR
    Circulation; 2015 Aug; 132(8):720-30. PubMed ID: 26304663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical importance of viability assessment in chronic ischemic heart failure.
    Calhoun WB; Mills RM; Drane WE
    Clin Cardiol; 1996 May; 19(5):367-9. PubMed ID: 8723594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome and the use of revascularization in patients with heart failure, suspected ischemic heart disease, and large reversible myocardial perfusion defects.
    Miller WL; Tointon SK; Hodge DO; Nelson SM; Rodeheffer RJ; Gibbons RJ
    Am Heart J; 2002 May; 143(5):904-9. PubMed ID: 12040356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selecting patients with ischemic cardiomyopathy for medical treatment, revascularization, or heart transplantation.
    Beller GA
    J Nucl Cardiol; 1997; 4(2 Pt 2):S152-7. PubMed ID: 9115077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revascularization in severe left ventricular dysfunction: the role of viability testing.
    Chareonthaitawee P; Gersh BJ; Araoz PA; Gibbons RJ
    J Am Coll Cardiol; 2005 Aug; 46(4):567-74. PubMed ID: 16098417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of reconstructive interventions in patients with ischemic cardiomyopathy.
    Shipulin VM; Pryakhin AS; Andreev SL; Shipulin VV; Kozlov BN
    Asian Cardiovasc Thorac Ann; 2021 Jul; 29(6):508-517. PubMed ID: 33342244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.